Delivery Order SPE2DB20D1109-SPE2DB25FN90X
Award Date
4/16/25
Potential Completion Date
5/7/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,851.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order to supply the medication Esbriet 801 mg tablet in quantities of 90s. The contract is a firm fixed-price, non-set-aside award with a completion date of May 20, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Esbriet 267 mg tablets, a pharmaceutical product, with a ceiling value of $3,425.95 and a period of performance through June 25, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,851.90 firm fixed-price delivery order is for the supply of 4,568,160,448 tablets of the medication Esbriet 267 mg. The contract has a performance period through May 28, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,311.50 firm fixed-price delivery order is for the supply of Esbriet 801 mg tablets, a specialty medication. The contract has an ultimate completion date of November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $13,246.00 for the supply of Esbriet 267 mg tablets. The contract, which has an ultimate completion date of October 16, 2024, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency responsible for providing medical supplies to the U.S. military. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,311.50, is a delivery order for the supply of the medication Esbriet 267 MG Capsule 270S. The contract has a firm fixed price pricing type and an ultimate completion date of November 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued at up to $3,311.50, is for the delivery of the prescription medication Esbriet (pirfenidone) 801 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00...
This contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Esbriet 801 mg tablets, a pharmaceutical product, with a completion date of February 5, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $3,311.50 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), which has a $999,999,999 ceiling value and runs through November 2026. The contract delivers Esbriet 801 mg tablets for use in federal healthcare programs. The award has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that provides a...
This federal contract award is a Delivery Order valued at $3,425.95 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The award covers the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that holds an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical. This IDC serves as a primary...